Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.53 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.53 |
| ▸ | GMPS | P49915 | 1/20 | 0.53 |
| ▸ | SLC28A1 | O00337 | 2/20 | 0.48 |
| ▸ | PI4KA | P42356 | 2/20 | 0.48 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.48 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.48 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.48 |
| ▸ | DPP4 | P27487 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.48 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.48 |
| ▸ | GAPDH | P04406 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.48 |
| ▸ | STAT6 | P42226 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29508945 | 1.00 | ADORA3 (0.53) | ADORA3ADORA2AGMPSSLC28A1PI4KA | |
| Tetrazole SCHEMBL27523959 | 0.91 | ADORA3 (0.46) | ADORA3ADORA2AGMPSSLC28A1PI4KA | |
| SCHEMBL8003530 | 0.89 | ADORA3 (0.53) | ADORA3ADORA2AGMPSSLC28A1PI4KA | |
| SCHEMBL30676636 | 0.88 | ADORA3 (0.53) | ADORA3ADORA2AGMPSSLC28A1PI4KA | |
| SCHEMBL5181220 | 0.88 | ADORA3 (0.53) | ADORA3ADORA2AGMPSSLC28A1PI4KA | |
| SCHEMBL277610 | 0.88 | ADORA3 (0.53) | ADORA3ADORA2AGMPSSLC28A1PI4KA | |
| SCHEMBL35210134 | 0.88 | ADORA3 (0.53) | ADORA3ADORA2AGMPSSLC28A1PI4KA | |
| Psicofuranine SCHEMBL29441281 | 0.88 | GMPS (0.61) | ADORA3ADORA2AGMPSSLC28A1PI4KA | |
| Psicofuranine SCHEMBL691065 | 0.88 | GMPS (0.61) | ADORA3ADORA2AGMPSSLC28A1PI4KA | |
| Psicofuranine SCHEMBL9389898 | 0.88 | GMPS (0.61) | ADORA3ADORA2AGMPSSLC28A1PI4KA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112301118-B | Method and kit for simultaneously obtaining RNA abundance and active RNA polymerase sites in full transcriptome range | 浙江大学 | 2022-05-13 | — | — | CN | claimed |
| CN-111154837-B | Method for detecting RNA N6-methyladenine modification in single base resolution in full transcriptome range | 浙江大学 | 2021-05-18 | — | — | CN | claimed |
| CN-112301118-A | Method and kit for simultaneously obtaining RNA abundance and active RNA polymerase sites in full transcriptome range | 浙江大学 | 2021-02-02 | — | — | CN | claimed |
| CN-111154837-A | Method and kit for detecting RNA N6-methyladenine modification in single base resolution in full transcriptome range | 浙江大学 | 2020-05-15 | — | — | CN | claimed |
| US-11859248-B2 | Nucleic acid modification and identification method | IMBA—INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH (AT) | 2024-01-02 | — | — | US | disclosed |
| CN-110520540-B | Nucleic acid modification and identification method | IMBA-莫利库尔生物技术研究所 | 2023-10-03 | — | — | CN | disclosed |
| CN-116685684-A | Compositions and methods for treating type 1a glycogen storage disease | 比姆医疗股份有限公司 | 2023-09-01 | — | — | CN | disclosed |
| WO-2023114963-A1 | COMPOSITIONS AND METHODS FOR SELECTIVELY LABELING SECONDARY AMINES | EMORY UNIVERSITY (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20230054714-A1 | NUCLEIC ACID MODIFICATION AND IDENTIFICATION METHOD | IMBA INST MOLEKULARE BIOTECH (AT) | 2023-02-23 | — | — | US | disclosed |
| CN-115279398-A | Compositions and methods for treating liquid cancers | 比姆医疗股份有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-114787385-A | Methods and systems for detecting nucleic acid modifications | 芝加哥大学 | 2022-07-22 | — | — | CN | disclosed |
| CN-114641567-A | Compositions and methods for editing mutations to allow transcription or expression | 比姆医疗股份有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-109952297-A | Compound | 奥斯陆大学 | 2019-06-28 | — | — | CN | disclosed |
| US-20190177785-A1 | NUCLEIC ACID MODIFICATION AND IDENTIFICATION METHOD | IMBA - INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH (AT) | 2019-06-13 | — | — | US | disclosed |
| WO-2018189367-A1 | NUCLEIC ACID MODIFICATION AND IDENTIFICATION METHOD | IMBA - INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH (AT) | 2018-10-18 | — | — | WO | disclosed |
| US-20080168707-A1 | Additive for hydrocarbon fuel and related processes consisting of compounds of adenosine phosphates | ENVIROFUELS LLC (US) | 2008-07-17 | — | — | US | disclosed |
| WO-2007136548-A2 | ADDITIVE FOR HYDROCARBON FUEL AND RELATED PROCESSES CONSISTING OF COMPOUNDS OF ADENOSINE PHOSPHATES | ENVIROFUELS, LLC (US) | 2007-11-29 | — | — | WO | disclosed |
| CN-1032815-C | Selective adenosine receptor agents | MERRELL DOW PHARMA (US) | 1996-09-18 | — | — | CN | disclosed |
| CN-1055181-A | SELECTIVE ADENOSINE RECEPTOR AGENTS | MERRELL DOW PHARMA (US) | 1991-10-09 | — | — | CN | disclosed |
| US-4992535-A | Cardiovascular disorders; side effect reduction | G. D. SEARLE & CO. (US) | 1991-02-12 | — | — | US | disclosed |